Techno Medica Co., Ltd. (6678.T)
JPY 1791.0
(-0.39%)
JPY 1791.0
(-0.39%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.95 Billion JPY | 10.98% |
| 2022 | 1.75 Billion JPY | -12.37% |
| 2021 | 1.95 Billion JPY | 17.51% |
| 2020 | 1.74 Billion JPY | 33.28% |
| 2019 | 1.35 Billion JPY | -20.16% |
| 2018 | 1.62 Billion JPY | 2.83% |
| 2017 | 1.74 Billion JPY | 6.35% |
| 2016 | 679.94 Million JPY | -14.62% |
| 2015 | 1.87 Billion JPY | -28.74% |
| 2014 | 2.33 Billion JPY | 9.0% |
| 2013 | 2.21 Billion JPY | 11.49% |
| 2012 | 1.98 Billion JPY | 6.13% |
| 2011 | 1.87 Billion JPY | 24.72% |
| 2010 | 1.49 Billion JPY | 14.07% |
| 2009 | 1.31 Billion JPY | -7.1% |
| 2008 | 1.41 Billion JPY | 0.56% |
| 2007 | 1.44 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 275.03 Million JPY | -69.3% |
| 2023 Q4 | 942.18 Million JPY | 132.95% |
| 2023 FY | - JPY | 10.98% |
| 2023 Q1 | 81.56 Million JPY | -90.12% |
| 2023 Q2 | 442 Million JPY | 441.89% |
| 2023 Q3 | 404.46 Million JPY | -8.49% |
| 2022 Q4 | 825.63 Million JPY | 118.75% |
| 2022 FY | - JPY | -12.37% |
| 2022 Q1 | 121.78 Million JPY | -86.28% |
| 2022 Q2 | 324.71 Million JPY | 166.62% |
| 2022 Q3 | 377.43 Million JPY | 16.23% |
| 2021 Q4 | 887.69 Million JPY | 191.57% |
| 2021 FY | - JPY | 17.51% |
| 2021 Q1 | 246.12 Million JPY | -69.77% |
| 2021 Q2 | 423.59 Million JPY | 72.11% |
| 2021 Q3 | 304.45 Million JPY | -28.13% |
| 2020 Q4 | 814.25 Million JPY | 120.34% |
| 2020 Q3 | 369.54 Million JPY | 13.83% |
| 2020 Q2 | 324.65 Million JPY | 305.72% |
| 2020 Q1 | 80.01 Million JPY | -80.07% |
| 2020 FY | - JPY | 33.28% |
| 2019 Q3 | 250.44 Million JPY | -31.81% |
| 2019 Q4 | 401.48 Million JPY | 60.3% |
| 2019 Q1 | 169.26 Million JPY | -75.01% |
| 2019 Q2 | 367.29 Million JPY | 116.99% |
| 2019 FY | - JPY | -20.16% |
| 2018 Q4 | 677.46 Million JPY | 243.49% |
| 2018 FY | - JPY | 2.83% |
| 2018 Q3 | 197.22 Million JPY | -60.54% |
| 2018 Q2 | 499.79 Million JPY | 185.33% |
| 2018 Q1 | 175.16 Million JPY | -72.97% |
| 2017 FY | - JPY | 6.35% |
| 2017 Q3 | 433.46 Million JPY | 222.48% |
| 2017 Q2 | 134.41 Million JPY | -36.18% |
| 2017 Q1 | 210.62 Million JPY | -66.64% |
| 2017 Q4 | 647.97 Million JPY | 49.49% |
| 2016 Q3 | 429.97 Million JPY | 556.61% |
| 2016 FY | - JPY | -14.62% |
| 2016 Q4 | 631.35 Million JPY | 46.83% |
| 2016 Q2 | 65.48 Million JPY | -75.71% |
| 2016 Q1 | 269.58 Million JPY | -63.31% |
| 2015 Q1 | 418.85 Million JPY | -59.26% |
| 2015 Q3 | 131.26 Million JPY | -82.26% |
| 2015 FY | - JPY | -28.74% |
| 2015 Q4 | 734.83 Million JPY | 459.82% |
| 2015 Q2 | 739.94 Million JPY | 76.66% |
| 2014 Q2 | 811.03 Million JPY | 266.07% |
| 2014 Q1 | 221.55 Million JPY | -75.64% |
| 2014 Q4 | 1.02 Billion JPY | 291.35% |
| 2014 FY | - JPY | 9.0% |
| 2014 Q3 | 262.69 Million JPY | -67.61% |
| 2013 FY | - JPY | 11.49% |
| 2013 Q2 | 663.12 Million JPY | 132.15% |
| 2013 Q1 | 285.64 Million JPY | -65.97% |
| 2013 Q4 | 909.33 Million JPY | 200.99% |
| 2013 Q3 | 302.11 Million JPY | -54.44% |
| 2012 Q3 | 314.63 Million JPY | -40.17% |
| 2012 Q2 | 525.9 Million JPY | 98.24% |
| 2012 FY | - JPY | 6.13% |
| 2012 Q1 | 265.28 Million JPY | -66.9% |
| 2012 Q4 | 839.31 Million JPY | 166.76% |
| 2011 Q2 | 466.18 Million JPY | 156.58% |
| 2011 Q1 | 181.69 Million JPY | -77.01% |
| 2011 FY | - JPY | 24.72% |
| 2011 Q3 | 383.94 Million JPY | -17.64% |
| 2011 Q4 | 801.52 Million JPY | 108.76% |
| 2010 Q1 | 114.37 Million JPY | -80.11% |
| 2010 Q3 | 145.82 Million JPY | -67.64% |
| 2010 Q2 | 450.59 Million JPY | 293.95% |
| 2010 FY | - JPY | 14.07% |
| 2010 Q4 | 790.15 Million JPY | 441.84% |
| 2009 FY | - JPY | -7.1% |
| 2009 Q2 | 472.42 Million JPY | 269.36% |
| 2009 Q1 | 127.9 Million JPY | -75.37% |
| 2009 Q3 | 140.48 Million JPY | -70.26% |
| 2009 Q4 | 574.99 Million JPY | 309.31% |
| 2008 Q4 | 519.35 Million JPY | 91.8% |
| 2008 Q2 | 568.41 Million JPY | 0.0% |
| 2008 Q3 | 270.77 Million JPY | -52.36% |
| 2008 FY | - JPY | 0.56% |
| 2007 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| DVx Inc. | 807.98 Million JPY | -141.74% |
| Seikagaku Corporation | 2.09 Billion JPY | 6.812% |
| Eiken Chemical Co., Ltd. | 5.7 Billion JPY | 65.763% |
| Create Medic Co., Ltd. | 1.39 Billion JPY | -40.379% |
| PHC Holdings Corporation | 39.08 Billion JPY | 95.003% |
| Rion Co., Ltd. | 4.37 Billion JPY | 55.372% |
| Nihon Kohden Corporation | 23.44 Billion JPY | 91.669% |
| Fukuda Denshi Co., Ltd. | 36.23 Billion JPY | 94.609% |
| Japan Lifeline Co., Ltd. | 12.39 Billion JPY | 84.236% |
| Japan Medical Dynamic Marketing, INC. | 3.27 Billion JPY | 40.329% |
| 3-D Matrix, Ltd. | 2.09 Billion JPY | 6.634% |
| CYBERDYNE Inc. | -2 Million JPY | 97760.9% |